Imexon

Imexon
Clinical data
ATC code	none;
Identifiers
	IUPAC name 4-imino-1,3-diazabicyclo[3.1.0]hexan-2-one;
CAS Number	59643-91-3 ;
PubChem CID	68791;
ChemSpider	62031 ;
UNII	8F63U28T2V;
KEGG	D08932 ;
CompTox Dashboard (EPA)	DTXSID1046895 ;
ECHA InfoCard	100.056.199
Chemical and physical data
Formula	C4H5N3O
Molar mass	111.104 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1/N=C(/N)C2N1C2;
	InChI InChI=1S/C4H5N3O/c5-3-2-1-7(2)4(8)6-3/h2H,1H2,(H2,5,6,8) ; Key:BIXBBIPTYBJTRY-UHFFFAOYSA-N ;
(what is this?) (verify)

Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.

External links

Amplimexon entry in the public domain NCI Dictionary of Cancer Terms

This article incorporates public domain material from the U.S. National Cancer Institute document: "Dictionary of Cancer Terms".

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.